CLINICAL PRACTICE GUIDELINE CNS-001 version 3 GLIOBLASTOMA Effective Date: September, 2012

First Page		Document Content
Date: 2013-12-13 15:15:49 Glioma Temozolomide Oligodendroglioma Adjuvant therapy Astrocytoma Radiation therapy Anaplastic thyroid cancer Astroblastoma Medicine Brain tumor Glioblastoma multiforme		CLINICAL PRACTICE GUIDELINE CNS-001 version 3 GLIOBLASTOMA Effective Date: September, 2012 Add to Reading List Source URL: www.albertahealthservices.ca Download Document from Source Website File Size: 182,98 KB Share Document on Facebook

	LNCSRobust Skull Stripping of Clinical Glioblastoma Multiforme Data DocID: 1rLcB - View Document
	Honoring those individuals who excel in their efforts to raise awareness and education around glioblastoma cancer. Nomination Form for GBM Heroes Please use this form to nominate your hero for the GBM Awards Program. Thi DocID: 1qtQg - View Document
	CABARET: Carboplatin and bevacizumab in recurrent glioblastoma study (Part 1) The CABARET trial is helping researchers answer an important health question. It is providing evidence for oncologists planning treatment for DocID: 1pDeC - View Document
	MayImproving Trial Success by Improving Tumor Assessment Jamal Gasmi, MD, PhD l Vice President & Global Leader Oncology & Hematology Drug Development, ICON Clinical Research James Conklin, MD, MS l Senior Vice Pre DocID: 1pCHm - View Document
	JOURNAL OF MAGNETIC RESONANCE IMAGING 20:555–Original Research Diffusion Tensor Eigenvector Directional Color Imaging Patterns in the Evaluation of Cerebral DocID: 1prM2 - View Document